-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA accepts Ultragenyx DTX401 BLA for priority review in GSDIa with Aug. 23, 2026 PDUFA date

Reuters·02/23/2026 13:30:33

Please log in to view news